Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis Pharma News

JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis

  • 01 November 2025
  • 5 hours ago

Johnson & Johnson MedTech launches Total Shoulder Replacement System Medical Devices News

Johnson & Johnson MedTech launches Total Shoulder Replacement System

  • 19 October 2025
  • 1 week ago

JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer Pharma News

JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer

  • 17 October 2025
  • 2 weeks ago

JnJ plans to separate Orthopaedics business Pharma News

JnJ plans to separate Orthopaedics business

  • 16 October 2025
  • 2 weeks ago

JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis Pharma News

JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis

  • 30 September 2025
  • 1 month ago

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis Pharma News

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis

  • 21 September 2025
  • 1 month ago

JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis Pharma News

JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis

  • 20 September 2025
  • 1 month ago

JnJ launches Shockwave Javelin Peripheral IVL Catheter in Europe Medical Devices News

JnJ launches Shockwave Javelin Peripheral IVL Catheter in Europe

  • 16 September 2025
  • 1 month ago

JnJ bags USFDA nod for bladder cancer treatment Inlexzo Oncology

JnJ bags USFDA nod for bladder cancer treatment Inlexzo

  • 10 September 2025
  • 1 month ago

USFDA Grants Fast Track Designation To JnJ Nipocalimab To Reduce Fetal Neonatal Alloimmune Thrombocytopenia Risk In Alloimmunized Pregnant Adults Obstetrics and Gynaecology

USFDA Grants Fast Track Designation To JnJ Nipocalimab To Reduce Fetal Neonatal Alloimmune Thrombocytopenia Risk In Alloimmunized Pregnant Adults

  • 19 July 2025
  • 3 months ago

Recent News

Madras HC grants bail to man accused of forging NE...

  • 01 November, 2025

AIIMS INI SS January 2026: 4 seats added in 2 spec...

  • 01 November, 2025

Treatment in Myocardial Infarction and Non-Obstruc...

  • 01 November, 2025

PG medical admissions 2025 commence in Bihar, chec...

  • 01 November, 2025

Assam to begin NEET PG 2025 counselling from Novem...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.